Peptoid Mimics of Antimicrobial Peptides Kill Bacteria by Disrupting Membranes — Just Like the Natural Peptides They're Based On

Eight peptoids with quaternized triazolium groups were synthesized and characterized. Their interactions with lipid bilayers modeling bacterial membranes (anionic) and eukaryotic membranes (zwitterionic) were studied using calcein leakage (membrane permeabilization), circular dichroism (CD) spectroscopy (secondary structure), fluorescence assays (membrane binding and localization), and solid-state NMR spectroscopy (lipid order parameter changes). Antibacterial activity was tested against Gram-positive and Gram-negative bacteria, and hemolytic activity was assessed using human red blood cells.

Understanding how peptoid antibiotics work at the molecular level is essential for rational design of next-generation antimicrobials. This study's demonstration that peptoid-membrane interactions directly predict antibacterial activity means researchers can now use relatively quick biophysical assays to screen and optimize peptoid candidates before expensive biological testing. The membrane-disruption mechanism also suggests peptoids may share the natural resistance-evading properties of antimicrobial peptides — bacteria struggle to develop resistance against agents that attack their fundamental membrane structure.

Peptoids occupy a strategic position between natural peptides and small-molecule drugs. They mimic peptide structures well enough to share their biological mechanisms but resist proteolysis and can be manufactured more cheaply using established sub-monomer synthesis. This study, published in the Journal of Medicinal Chemistry, provides the biophysical foundation for rational peptoid antibiotic design by proving the mechanism-activity relationship. The triazolium modification adds both a permanent positive charge and metabolic stability, potentially addressing two key limitations of natural antimicrobial peptides.

The study used model lipid bilayers rather than whole bacterial cells for most biophysical experiments, which may not fully capture the complexity of real bacterial membranes (which contain proteins, lipopolysaccharides, and peptidoglycan). In vivo efficacy and pharmacokinetics were not assessed. The correlation between membrane activity and antibacterial activity, while excellent, was established with a limited set of eight peptoids. Long-term resistance development was not studied. Selectivity between bacterial and mammalian membranes, while demonstrated via hemolysis assays, was not tested in more complex mammalian cell models.